{"id":"https://openalex.org/W2030153745","doi":"https://doi.org/10.1212/wnl.59.8.1210","title":"Eletriptan vs sumatriptan: A double-blind, placebo-controlled, multiple migraine attack study","display_name":"Eletriptan vs sumatriptan: A double-blind, placebo-controlled, multiple migraine attack study","alternate_titles":[],"publication_year":2002,"publication_date":"2002-10-22","ids":{"openalex":"https://openalex.org/W2030153745","doi":"https://doi.org/10.1212/wnl.59.8.1210","mag":"2030153745","pmid":"https://pubmed.ncbi.nlm.nih.gov/12391349"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.59.8.1210","doi":"https://doi.org/10.1212/wnl.59.8.1210","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.59.8.1210","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2030153745"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083338647","display_name":"Giorgio Sandrini","orcid":"https://orcid.org/0000-0001-6234-6777","observed_orcids":["https://orcid.org/0000-0001-6234-6777"]},"institutions":[{"id":"https://openalex.org/I25217355","display_name":"University of Pavia","ror":"https://ror.org/00s6t1f81","country_code":"IT","type":"education","lineage":["https://openalex.org/I25217355"]},{"id":"https://openalex.org/I4210095701","display_name":"Fondazione Istituto Neurologico Nazionale Casimiro Mondino","ror":"https://ror.org/009h0v784","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210095701","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. Sandrini","raw_affiliation_strings":["University Centre for Adaptive Disorders and Headache, IRCCSC. Mondino Foundation, Pavia, Italy. gsandrini@unipv.it","Fondazione Istituto Neurologico Casimiro Mondino"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Centre for Adaptive Disorders and Headache, IRCCSC. Mondino Foundation, Pavia, Italy. gsandrini@unipv.it","institution_ids":["https://openalex.org/I25217355"]},{"raw_affiliation_string":"Fondazione Istituto Neurologico Casimiro Mondino","institution_ids":["https://openalex.org/I4210095701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065139294","display_name":"Martti A. F\u00e4rkkil\u00e4","orcid":"https://orcid.org/0000-0002-0250-8559","observed_orcids":["https://orcid.org/0000-0002-0250-8559"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Fa\u0308rkkila\u0308","raw_affiliation_strings":["#N##TAB##TAB##TAB##TAB# University of Helsinki#N##TAB##TAB##TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"#N##TAB##TAB##TAB##TAB# University of Helsinki#N##TAB##TAB##TAB#","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112104095","display_name":"Gary Burgess","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. Burgess","raw_affiliation_strings":["Pfizer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"E. Forster","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E. Forster","raw_affiliation_strings":["Pfizer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018060366","display_name":"Scott Haughie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Haughie","raw_affiliation_strings":["Pfizer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.2109,"has_fulltext":false,"cited_by_count":105,"citation_normalized_percentile":{"value":0.95761702,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"59","issue":"8","first_page":"1210","last_page":"1217"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10420","display_name":"Intracranial Aneurysms: Treatment and Complications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/eletriptan","display_name":"eletriptan","score":0.9950000047683716},{"id":"https://openalex.org/keywords/sumatriptan","display_name":"sumatriptan","score":1.0},{"id":"https://openalex.org/keywords/migraine","display_name":"migraine","score":0.7929999828338623},{"id":"https://openalex.org/keywords/acute-migraine-treatment","display_name":"acute migraine treatment","score":0.9110000133514404},{"id":"https://openalex.org/keywords/triptans","display_name":"triptans","score":0.9269999861717224},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.8130000233650208},{"id":"https://openalex.org/keywords/patient-acceptability","display_name":"patient acceptability","score":0.7200000286102295},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.6460000276565552}],"concepts":[{"id":"https://openalex.org/C2778871607","wikidata":"https://www.wikidata.org/wiki/Q416978","display_name":"Sumatriptan","level":4,"score":0.9930788278579712},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8765941262245178},{"id":"https://openalex.org/C2778541695","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Migraine","level":2,"score":0.7801085710525513},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7287290692329407},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.683753252029419},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18431487679481506},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.07034161686897278},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008881","descriptor_name":"Migraine Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008881","descriptor_name":"Migraine Disorders","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D008881","descriptor_name":"Migraine Disorders","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014363","descriptor_name":"Tryptamines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016015","descriptor_name":"Logistic Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018170","descriptor_name":"Sumatriptan","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018170","descriptor_name":"Sumatriptan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1212/wnl.59.8.1210","doi":"https://doi.org/10.1212/wnl.59.8.1210","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.59.8.1210","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},{"id":"pmid:12391349","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12391349","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W48338217","https://openalex.org/W1986115245","https://openalex.org/W1992142025","https://openalex.org/W1999193930","https://openalex.org/W2005537302","https://openalex.org/W2025006950","https://openalex.org/W2030335080","https://openalex.org/W2036993928","https://openalex.org/W2039623332","https://openalex.org/W2056320680","https://openalex.org/W2072888650","https://openalex.org/W2074550961","https://openalex.org/W2092450423","https://openalex.org/W2099275034","https://openalex.org/W2126194551","https://openalex.org/W2133451210","https://openalex.org/W2149133494","https://openalex.org/W2158846562","https://openalex.org/W2443846900"],"related_works":["https://openalex.org/W48338217","https://openalex.org/W1983983524","https://openalex.org/W1967755266","https://openalex.org/W2054233983","https://openalex.org/W2141137381","https://openalex.org/W2431536808","https://openalex.org/W2050659421","https://openalex.org/W1995178155","https://openalex.org/W2013751385"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"compare":[2],"the":[3,22,73,79,273],"efficacy":[4,233],"of":[5,25,32,45,49,53,58,177,234,243,276],"oral":[6,14],"eletriptan,":[7,46,50],"40":[8,43,138,217],"mg":[9,17,44,48,52,57,159,171,202,218,249,263],"and":[10,13,18,94,105,118,131,140,145,189,254,264,270,278],"80":[11,47,152,158,201,265],"mg,":[12,20],"sumatriptan,":[15,54],"50":[16,51,112,170,248],"100":[19,56,125],"in":[21,76,206,225,272],"acute":[23,274],"treatment":[24,275],"migraine.":[26],"METHODS:":[27],"Patients":[28],"with":[29,240],"a":[30,161,280],"history":[31],"migraine":[33,277],"(n":[34],"=":[35],"1,008)":[36],"were":[37,89,179,256],"randomly":[38],"assigned":[39],"to":[40,60,63,78,181,221],"receive":[41],"placebo,":[42],"or":[55],"sumatriptan":[59,111,124,169,182,214,223,247,255],"treat":[61],"up":[62],"three":[64],"attacks.":[65],"Early":[66],"headache":[67,83,163,187,204],"response":[68,87,164,188,205],"(at":[69],"1":[70,92,103,116,129,143],"hour)":[71],"was":[72,219,238],"primary":[74],"endpoint,":[75,81],"addition":[77],"standard":[80],"2-hour":[82],"response.":[84,282],"RESULTS:":[85],"Headache":[86],"rates":[88,242],"12%":[90],"at":[91,96,102,107,115,120,128,133,142,147,183],"hour":[93,104,117,130,144],"31%":[95],"2":[97,108,121,134,148,184],"hours":[98,109,122,135,149,185],"for":[99,110,123,136,150,186],"placebo;":[100],"24%":[101],"50%":[106],"mg;":[113,126,139],"27%":[114],"53%":[119],"30%":[127],"64%":[132],"eletriptan":[137,151,157,178,200,236,261],"37%":[141],"67%":[146],"mg.":[153],"More":[154],"patients":[155,167,198,211],"receiving":[156,168,212],"achieved":[160,203],"1-hour":[162],"than":[165,209,246],"did":[166,210],"(p":[172,193,228,250],"<":[173,194,229,251],"0.05).":[174,195,252],"All":[175],"doses":[176,224,237],"superior":[180,220,232],"complete":[190],"pain":[191],"relief":[192],"Significantly":[196],"more":[197],"on":[199],"all":[207],"attacks":[208],"either":[213],"dose.":[215],"Eletriptan":[216,253],"both":[222,235],"functional":[226],"improvement":[227],"0.005).":[230],"The":[231],"associated":[239],"higher":[241],"patient":[244],"acceptability":[245],"well":[257],"tolerated.":[258],"CONCLUSION:":[259],"Oral":[260],"(40":[262],"mg)":[266],"is":[267],"effective,":[268],"safe,":[269],"tolerable":[271],"yields":[279],"consistent":[281]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2030153745","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
